Header Logo

Connection

Ralf Janknecht to Intracellular Signaling Peptides and Proteins

This is a "connection" page, showing publications Ralf Janknecht has written about Intracellular Signaling Peptides and Proteins.
  1. Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1. Mol Cancer. 2014 May 06; 13:103.
    View in: PubMed
    Score: 0.095
  2. Nephrin and Podocin functions are highly conserved between the zebrafish pronephros and mammalian metanephros. Mol Med Rep. 2014 Feb; 9(2):457-65.
    View in: PubMed
    Score: 0.092
  3. Fluvastatin interferes with hepatitis C virus replication via microtubule bundling and a doublecortin-like kinase-mediated mechanism. PLoS One. 2013; 8(11):e80304.
    View in: PubMed
    Score: 0.092
  4. Cell type-specific inhibition of the ETS transcription factor ER81 by mitogen-activated protein kinase-activated protein kinase 2. J Biol Chem. 2001 Nov 09; 276(45):41856-61.
    View in: PubMed
    Score: 0.039
  5. Signalling pathways: jack of all cascades. Curr Biol. 1996 Jan 01; 6(1):16-9.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.